Equity Profile

ADPT

Adaptive Biotechnologies Corporation

Health CareLife Sciences Tools & Services$3.9B

Aug4Tue

Pre-Earnings Brief

UpcomingQ2-2026After Close5:00 PM EDT

Company Snapshot

Adaptive Biotechnologies Corporation focuses on using advanced technology to analyze the immune system, which is crucial for developing new treatments for diseases. As part of the Health Care sector, the company's work is particularly relevant in the context of personalized medicine and the growing demand for innovative healthcare solutions.

Key Metrics to Watch

EPS

Earnings per share is a key indicator of profitability, and investors will be watching to see if the company can narrow its losses.

$-0.10

Revenue

Revenue growth is critical for assessing the company's market traction and overall health, especially in a competitive industry.

$72M

Wall Street expectations, options signals, track record, and call prep available with Pro.

ADPT Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+37.94%

Avg Stock Reaction

-0.91%

Last Quarter Recap

In the last quarter, Adaptive Biotechnologies reported an EPS of $-0.13, which was better than expected, indicating some operational improvements. However, the stock still declined by nearly 5% the following day, reflecting investor caution.

Management Promises & Guidance

Expectations

Wall Street Expectations

Analysts expect Adaptive Biotechnologies to report a narrower loss in EPS this quarter, alongside modest revenue growth. The market is keen to see if the company can maintain its positive surprise trend.

Bull Case

If the company beats EPS estimates and shows strong revenue growth, it could signal a turnaround and boost investor confidence, potentially leading to a significant stock price increase.

Bear Case

On the other hand, if the company fails to meet expectations, especially in revenue, it could raise concerns about its growth prospects, leading to a sharp decline in the stock price.

Key Metrics to Watch

EPS

$-0.10

Earnings per share is a key indicator of profitability, and investors will be watching to see if the company can narrow its losses.

Revenue

$72M

Revenue growth is critical for assessing the company's market traction and overall health, especially in a competitive industry.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will the company achieve revenue of at least $72M this quarter?

Meeting or exceeding this revenue target will be crucial for demonstrating growth and market demand for its products.

Can Adaptive Biotechnologies narrow its EPS loss to $-0.10 or better?

A smaller loss would indicate improved operational efficiency and could positively influence investor sentiment.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating the company's potential for revenue growth given recent operational improvements and market demand for its services.

Supporting Evidence

The company has consistently surprised on EPS, suggesting potential for continued operational efficiency.

Options pricing indicates a high expected move, reflecting uncertainty that could be resolved positively.

The recent trend of narrowing losses may not be fully factored into current estimates.

Key Risk

If revenue comes in above $72M, it could significantly shift market perception and expectations.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is weighing the potential for recovery against the backdrop of previous earnings surprises and current operational performance.

Bull Confirmed If

Achieving revenue growth of at least $72M and an EPS loss of $-0.10 or better would confirm a positive outlook.

Bear Confirmed If

Failing to meet the revenue target or reporting a larger EPS loss would indicate ongoing challenges.

Pre-Earnings Positioning

Options Market

Implied Move

±37.62%

Historical Avg

±2.6%

Pricing rich

The options market is pricing in a significant move around the earnings announcement, indicating heightened uncertainty or expectations for volatility.

Options are pricing ±37.6% while ADPT has averaged ±2.6% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.8%

30d HV

53.6%

Calls (1K)P/C Ratio: 0.31Puts (400)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If the company beats expectations, history suggests a potential stock increase of around 2.61%, confirming a positive trend.

In-Line / Cautious

If results are in line with expectations, the stock may react cautiously, reflecting the market's mixed sentiment.

Miss

A miss could lead to a decline, with historical patterns indicating a potential drop of around 4.97%.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches or partnerships that could drive revenue growth.
2Management's commentary on operational efficiencies and cost management strategies.
3Insights into market demand for their services and how it compares to previous quarters.
4Guidance on future revenue expectations and any changes in market strategy.
5Any discussion regarding competitive landscape and how the company plans to differentiate itself.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Aug3

ONBMO

ON Semiconductor Corporation

PreviewView

Aug3

LBMO

Company Snapshot

Key Metrics to Watch

EPS

Earnings per share is a key indicator of profitability, and investors will be watching to see if the company can narrow its losses.

$-0.10

Revenue

Revenue growth is critical for assessing the company's market traction and overall health, especially in a competitive industry.

$72M

Wall Street expectations, options signals, track record, and call prep available with Pro.

ADPT Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+37.94%

Avg Stock Reaction

-0.91%

Last Quarter Recap

Management Promises & Guidance

Expectations

Wall Street Expectations

Bull Case

If the company beats EPS estimates and shows strong revenue growth, it could signal a turnaround and boost investor confidence, potentially leading to a significant stock price increase.

Bear Case

On the other hand, if the company fails to meet expectations, especially in revenue, it could raise concerns about its growth prospects, leading to a sharp decline in the stock price.

Key Metrics to Watch

EPS

$-0.10

Earnings per share is a key indicator of profitability, and investors will be watching to see if the company can narrow its losses.

Revenue

$72M

Revenue growth is critical for assessing the company's market traction and overall health, especially in a competitive industry.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will the company achieve revenue of at least $72M this quarter?

Meeting or exceeding this revenue target will be crucial for demonstrating growth and market demand for its products.

Can Adaptive Biotechnologies narrow its EPS loss to $-0.10 or better?

A smaller loss would indicate improved operational efficiency and could positively influence investor sentiment.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating the company's potential for revenue growth given recent operational improvements and market demand for its services.

Supporting Evidence

The company has consistently surprised on EPS, suggesting potential for continued operational efficiency.

Options pricing indicates a high expected move, reflecting uncertainty that could be resolved positively.

The recent trend of narrowing losses may not be fully factored into current estimates.

Key Risk

If revenue comes in above $72M, it could significantly shift market perception and expectations.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is weighing the potential for recovery against the backdrop of previous earnings surprises and current operational performance.

Bull Confirmed If

Achieving revenue growth of at least $72M and an EPS loss of $-0.10 or better would confirm a positive outlook.

Bear Confirmed If

Failing to meet the revenue target or reporting a larger EPS loss would indicate ongoing challenges.

Pre-Earnings Positioning

Options Market

Implied Move

±37.62%

Historical Avg

±2.6%

Pricing rich

The options market is pricing in a significant move around the earnings announcement, indicating heightened uncertainty or expectations for volatility.

Options are pricing ±37.6% while ADPT has averaged ±2.6% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.8%

30d HV

53.6%

Calls (1K)P/C Ratio: 0.31Puts (400)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If the company beats expectations, history suggests a potential stock increase of around 2.61%, confirming a positive trend.

In-Line / Cautious

If results are in line with expectations, the stock may react cautiously, reflecting the market's mixed sentiment.

Miss

A miss could lead to a decline, with historical patterns indicating a potential drop of around 4.97%.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches or partnerships that could drive revenue growth.
2Management's commentary on operational efficiencies and cost management strategies.
3Insights into market demand for their services and how it compares to previous quarters.
4Guidance on future revenue expectations and any changes in market strategy.
5Any discussion regarding competitive landscape and how the company plans to differentiate itself.